Memory and effector T cells modulate subsequently primed T cell responses to the same antigen. However, little is known about the impact of pre-existing memory and effector T cell immunity on subsequently primed immune responses to unrelated antigens. Here, we showed that an antigen-primed first wave of Th1 and Th2 immunity enhanced or inhibited the subsequently primed T cell immunity to an unrelated antigen, depending on whether the second antigen was administered in the same or opposite type of adjuvant. The regulatory effects of the first wave of T cell immunity on the subsequent T cell responses to an unrelated antigen attenuated with time. Notably, following challenge with the second antigen, there was a mutual cross-regulation between the first and second wave of humoral responses to unrelated antigens.
Introduction:
Antigen-specific CD4 + T cell responses have been divided into two subsets, Th1 and Th2, based on their effector function and their cytokine profiles [1] [2] [3] . The Th1/Th2 paradigm provides a useful framework for understanding the pathogenesis of certain infectious diseases as well as tissue-specific autoimmune diseases [4] [5] [6] [7] [8] [9] . While Th1 responses are necessary to clear infectious virus and intracellular parasitic bacteria, Th2 responses predominantly promote humoral responses that can effectively prevent toxin-related bacterial infection, particularly in the mucosal surface [10] [11] [12] [13] . Thus, the development of the appropriate type of T cell immunity is critical for successful vaccination and eradication of infectious organisms.
Much research has focused on developing adjuvants that guide immune responses toward a desired phenotype. For example, injection of antigen in complete Freund's adjuvant (CFA)
usually induces a Th1 biased response, while administration of antigen in incomplete Freund's adjuvant (IFA) or Alum tends to promote a unipolar Th2 response [14, 15] . Existing memory T cell responses usually enhance the same type of secondary immune responses after re-exposure to their cognate antigen, which are characterized by rapid and strong T cell recall proliferation [16] [17] [18] . However, the existing memory and effector T cell responses can also inhibit the subsequently primed T cell responses to the same antigen. Mice that were neonatally injected with antigen in IFA failed to generate proliferative, and IL-2 recall responses to that antigen when challenged in CFA later [19] . Thus, the existing memory T cell responses can enhance or down-regulate secondary responses to the same antigen, depending on the type of T cell response primed by antigen in the same or opposite type of adjuvant. However, little is known about the effect of pre-existing memory and effector Th1 or Th2 immunity on subsequently primed 4 immune responses to unrelated antigens. Furthermore, treatment with antigen in IFA to induce antigen-specific Th2 responses has been associated with inhibition of Th1 autoimmunity [20] [21] [22] [23] .
On the other hand, administration of antigen in modes that prime Th1 responses has been shown to inhibit Th2-mediated mucosal inflammation [24, 25] . Whether the second wave of immune responses primed by challenging with an unrelated antigen modulates the existing memory and effector CD4+ T cell responses remains to be determined.
Notably, epidemiological studies have found that prior exposure to tuberculosis is associated with a reduction in incidence and severity of atopic disease [26] . These results suggest that pre-existing memory and effector Th1 responses to tuberculosis antigens have a long-term inhibitory affect on an individual's propensity to develop spontaneous Th2-type autoimmunity.
If an individual's history of prior immune exposures shapes the quality or quantity of immune responses to subsequent challenges, it could have important implications for understanding susceptibility to autoimmune disease, the variations in human immune responses to pathogens, and may suggest improved protocols for effective vaccination.
To explore the consequence of the influence of different waves of immune responses to unrelated antigens, we immunized neonates with a prototypic antigen in IFA or CFA to establish the first wave of Th2 or Th1 responses, respectively. We then characterized immune responses following challenge with another antigen in the same or opposite type of adjuvant. We found that memory and effector T cells modulated subsequent immune responses to unrelated antigens.
Thus, immunization with one antigen not only primes immune responses to that antigen, but also influences subsequent immune responses to other unrelated antigens. We discuss the implications of these findings for understanding the development of determinant spreading in autoimmune disease and vaccination strategies.
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Materials and Methods
Mice.
Balb/c H-2d and C57BL/6 H-2b mice were obtained from Jackson Laboratory and bred under specific pathogen free conditions. Both female and male mice were used in this study.
Antigens and immunization.
Hen eggwhite lysozyme (HEL), and chicken ovalbumin (OVA) were purchased from Sigma (St. Louis). IFA was purchased from Invitrogen (Grand Island, NY) and CFA was made by mixing M. tuberculosis H37 RA (Difco Laboratories, Detroit, MI) at 2.0 mg/ml of IFA. Individual antigen was mixed with the IFA or CFA at 2.0 mg/ml and emulsified. Individual mice were injected with 50 μl (100 μg) Antigen i.p or s.c., as specified.
ELISPOT analysis.
Splenic mononuclear cells were isolated from antigen-treated mice at different time points post-immunization, and the frequency of antigen-specific T cells secreting IFNγ, IL-4, and IL-5 was determined using a modified ELISPOT assay, as previously described [23] . Briefly, 10 6 splenic mononuclear cells were added per well (in duplicate) to an ELISPOT plate which had been coated with cytokine capture antibodies and incubated with antigen (100 μg/ml) at 24 hrs for IFNγ, or 40 hrs for IL-4 and IL-5 detection. After washing, biotinylated detection antibodies were added and the plates were incubated at 4°C overnight. Bound secondary antibodies were visualized using HRP-streptoavidin (DAKO Corp.) and 3-amino-9-ethylcarbazole. Antibodies R4-6A2/XMG 1. We characterized splenic T cell immunity to both antigens by ELISPOT assays when the mice were at 6 wks of age ( Fig. 1 C and D and Th2 responses to OVA (Fig. 3 B and D) . Overall, our findings demonstrate that the first wave of immunity modulates subsequent T cell responses primed by an unrelated antigen in an opposite type of adjuvant. (Fig. 6 C, p<0.045) . Similarly, the preexisting immune responses to OVA also modulated subsequently primed humoral responses to HEL when administered in an opposite type of adjuvant ( Fig. 6 B and D) . Finally, challenge with an unrelated antigen in an opposite type of adjuvant modulated the isotype of humoral responses to antigen that the animal had been previously sensitized to. For example, while mice that were immunized with OVA/IFA developed unipolar IgG1 antibodies against OVA (Fig. 6 A) , mice that were neonatally sensitized with OVA/IFA and challenged with HEL/CFA displayed both IgG1 and increased levels of IgG2a antibodies against OVA (Fig. 6 A, p<0 .001). Challenge with HEL/IFA caused mice that were neonatally sensitized with OVA/CFA to produce higher levels of IgG1 antibodies against OVA (Fig 6 C, We characterized T cell immunity to the injected antigen by ELISPOT assays at 6, 10, or 14 wks of age ( Fig. 7 A and B) . Control mice that received one immunization with OVA/IFA or OVA/CFA developed comparable levels of polarized Th2 or Th1 cell responses to OVA, respectively (Fig. 7 A) . The neonatally primed Th2 responses to OVA appeared to be well maintained as the frequency of IL-5 secreting T cells only slightly reduced when tested at 14 wks of age (Fig. 7 B) . However, the frequency of IFNγ-secreting T cells primed by neonatal immunization with OVA/CFA dramatically decreased by about 50% when tested at 10 wks of age and further reduced at 14 wks of age (Fig. 7 B) compared to that in mice primed at those ages (Fig. 7 A) . Immunization with HEL induced a similar pattern of T cell responses in both strains of mice (data not shown). Thus, the neonatally primed Th1 and Th2 responses appeared to have different capacities to sustain over time.
Memory and effector T cells, but not
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The attenuation of primed T cell responses over time should also diminish their impact on subsequent T cell responses primed by an unrelated antigen. To test this contention, we neonatally injected Balb/c, or C57BL/6 mice with one antigen in one type of adjuvant and then challenged them with a second antigen in the opposite type of adjuvant at 4, 8, or 12 wks of age.
Two wks after challenge with the second antigen, we characterized T cell immunity to both antigens by ELISPOT assays. As previously described, the second wave of T cell immunity had no impact on the unipolar T cell responses induced by neonatal immunization. Mice that were sensitized with HEL and challenged with OVA at 4, 8, or 12 wks of age still displayed unipolar T cell immunity to HEL. We found that the levels of T cell responses to HEL gradually attenuated over time (data not shown), similar to that in control groups of mice that did not receive the challenge (Fig. 7 B) . Notably, the impact of pre-existing Th1 immunity on subsequent T cell responses to an unrelated antigen primed by antigen in IFA attenuated over time. For example, challenge with OVA/IFA at 4 wks of age promoted not only Th2, but also Th1 responses to OVA in mice that were neonatally sensitized with HEL/CFA when tested at 6 wks of age (Fig. 7 C) . However, when challenged at 8 or 12 wks of age and tested at 10 or 14 wks of age, T cell responses to OVA gradually became more Th2-polarized. Indeed, by 14 wks of age the magnitude of unipolar Th2 responses was similar to the control group that received one immunization with OVA/IFA (Fig. 7 A) . Thus, over time, the first wave of Th1 immunity no longer impacted the second wave of T cell responses.
Similarly, the influence of the first wave of Th2 responses on subsequently primed T cell immunity to an unrelated antigen primed by antigen in CFA also decreased as the interval of time between immunizations increased. For example, mice neonatally sensitized with HEL/IFA and then challenged with OVA/CFA at 4 wks of age displayed mixed Th1 and Th2 responses to OVA when tested at 6 wks of age. When challenged at 8 or 12 wks of age and tested at 10 or 14 wks of age respectively, the mice progressively developed more Th1-biased responses to OVA (Fig. 7 D) . A similar pattern of T cell immunity to HEL developed in mice neonatally sensitized with OVA following challenge with HEL in an opposite type of adjuvant at different ages (data not shown). Thus, although many memory and effector Th2 or Th1 cells responding to the first antigen still existed in vivo they had little effect on the subsequent T cell response when primed by an unrelated antigen at 12 wks of age. Our data indicate that the interference of the first wave of T cell immunity with the subsequently primed T cell responses to an unrelated antigen attenuated over time.
Discussion:
We studied the regulation of different waves of immune responses to unrelated antigens The intra-group variation was less than 15% of the mean number of SFC. A similar pattern of T cell responses to HEL was observed in mice neonatally sensitized with OVA and challenged with HEL (data not shown). C57BL/6 mice displayed a similar pattern of T cell immunity 
